Loading clinical trials...
Loading clinical trials...
Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura (ITP)
Conditions
Interventions
Inactivated Trivalent Influenza vaccine
Locations
3
United States
University of California, Los Angeles
Los Angeles, California, United States
Emory University School of Medicine
Atlanta, Georgia, United States
Children's Hospital
Boston, Massachusetts, United States
Start Date
October 1, 2004
Completion Date
March 1, 2006
Last Updated
October 25, 2012
NCT06722235
NCT04890041
NCT04014413
NCT07426107
NCT00621894
NCT00508820
Lead Sponsor
Neufeld, Ellis J, MD, PhD
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions